Company news
Eurobio-scientific Sa (EURONEXT:ALERS) news
Eurobio-scientific Sa news releases on 6ix. Latest, Sep 24, 2026: Eurobio Scientific: Results for the first semester of fiscal year 2026
Press releases & updates
Eurobio Scientific: Results for the first semester of fiscal year 2026
September 24, 2026
Eurobio Scientific: COMMUNIQUÉ DU 24 SEPTEMBRE 2026 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ
September 23, 2026
Eurobio Scientific: EB Development, actionnaire majoritaire d’Eurobio Scientific, annonce son intention de déposer une offre publique de retrait suivie d'un retrait obligatoire, au prix de 25,30 € par action
September 15, 2026
Eurobio Scientific: First half of 2026, Continuation of the strategic transformation
July 28, 2026
Eurobio Scientific: First half of 2026, Continuation of the strategic transformation
July 27, 2026
Eurobio Scientific finalizes the acquisition of CareDX’s transplant Lab Product division
July 1, 2026
Eurobio Scientific finalise l'acquisition de la division « Lab Products » de CareDX dédiée à la transplantation
June 30, 2026
Eurobio Scientific: ERRATUM : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
June 16, 2026
Eurobio scientific signs definitive agreement to acquire CareDx’s transplant Lab Product division
April 16, 2026
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
April 15, 2026
EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS
April 10, 2026
Eurobio Scientific: 2025 FY revenue
January 27, 2026
EUROBIO SCIENTIFIC: REPLACEMENT OF A STATUTORY AUDITOR
December 22, 2025
ABL Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its VELA Product Line in a Targeted Segment of the French Market
November 14, 2025
EUROBIO SCIENTIFIC : RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2025
October 13, 2025
EUROBIO SCIENTIFIC: RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025
September 24, 2025
Eurobio Scientific completes the acquisition of Life Science unit of Voden Medical Instruments Spa in Italy
July 1, 2025
Eurobio Scientific: EB Development rises above 90% threshold
May 19, 2025
Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024
April 29, 2025
Eurobio Scientific: 2024 annual results
April 28, 2025
Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
December 19, 2024
Eurobio Scientific Completes Acquisition of Endopredict Genomic Test from Myriad Genetics
August 5, 2024
EUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICS
August 2, 2024
Eurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENT // PROPOSED TENDER OFFER
July 31, 2024
Eurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENT // PROPOSED TENDER OFFER
July 31, 2024